Description

Ensure Tight Control over this Menace with…

 

COMPOSITION

Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin Hcl 500 mg (In Extended Release form

INDICATION

• Type 2 Diabetes
• Insulin Resistance
• Pre – Gestational

ZITANEO-D-MET 500

DAPAGLIFLOZIN

• A highly potent, reversible & selective sodium glucose cotransporter-2 inhibitor
• Early administered, selective inhibitor of dipeptidyl peptidase-4
• Offers protective effect on the pancreatic beta cells thus limiting the progression of disease.’
• Promotes glucose filtration through the kidney and into the urine to be eliminated from the body
• Facilitates weight loss, BP reduction, protects kidney

     SITAGLIPTIN

• Early administered, selective inhibitor of dipeptidyl peptidase-4
  Offers a protective effect on the pancreatic beta cells thus limiting
• The progression of the disease.’
• Safe with less incidence of hypoglycemia

   METFORMIN

• Provides additive glycemic improvement
• Controls body weight & body mass index